
SensArs
Revolutionizing Neuromodulation for Treatment of Diabetic Neuropathy
SensArs is a hardware company. It has recorded $1.2M in funding (partial USD total), most recently a Pre-Seed in June 2024.
- Website
- sensars.com
- Partial USD Funding Total
- $1.2M
- Last Round
- $1.2M Pre-SeedJun 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds for this company. to use credits for reveals, or explore the API.
About
Sensars develops breakthrough neurostimulation tech using real-time gait data to restore foot sensation in diabetics, preventing ulcers, amputation, falls and treating pain.
Funding History
Jun 2024
1 more funding event
- Pre-seed
Funding: Pre-Seed. Amounts, valuations, and investors where available.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
- Cloud/Infrastructure ×1
- Frontend ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries

Zipline operates an autonomous delivery service that transports medical supplies, food, and retai...
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
Juul Labs develops vapor products designed to offer adult smokers an alternative to combustible c...
Healthcare cost management company providing data analytics and network-based payment solutions t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sensars"><img src="https://indexed.vc/api/badge/company/sensars" alt="SensArs on Indexed.vc" width="260" height="76" /></a>